Beijing Tong Ren Tang Chinese Medicine Company Limited
HKSE 3613.HK
Beijing Tong Ren Tang Chinese Medicine Company Limited Operating Cash Flow for the year ending December 31, 2023: USD 59.00 M
-
Beijing Tong Ren Tang Chinese Medicine Company Limited Operating Cash Flow for the year ending December 31, 2022 was USD 70.08 M, a -29.68% change year over year.
-
Beijing Tong Ren Tang Chinese Medicine Company Limited Operating Cash Flow for the year ending December 31, 2021 was USD 99.66 M, a 565.92% change year over year.
-
Beijing Tong Ren Tang Chinese Medicine Company Limited Operating Cash Flow for the year ending December 31, 2020 was USD 14.97 M, a -78.83% change year over year.
-
Beijing Tong Ren Tang Chinese Medicine Company Limited Operating Cash Flow for the year ending December 31, 2019 was USD 70.71 M, a -4.12% change year over year.
| Date | Operating Cash Flow | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities | Dividends Paid |
|---|
Don’t Miss A Beat
| CEO | Mr. Wang Chi |
| IPO Date | May 7, 2013 |
| Location | Hong Kong |
| Headquarters | Office Tower |
| Employees | 779 |
| Sector | Healthcare |
| Industries | |
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of Chinese medicine and healthcare products to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and treatment services. The company operates 23 retail outlets in Hong Kong and 46 retail outlets in other countries and regions in Asia, Oceania, North America, and Europe. It markets its products under the Tong Ren Tang brand. The company was founded in 1669 and is based in Wan Chai, Hong Kong.
Past 5 years
USD 2.28
USD 0.63
USD 0.67
StockViz Staff
February 3, 2025
Any question? Send us an email